FGF8 and adenocarcinoma: Even though the results of this study demonstrate that FGF8 and FGF18 are independent prognostic factors in patients with adenocarcinomas of the esophago-gastric junction, our study has certain limitations: one is the potential selection bias which was inevitably associated with only partial availability of tumor tissue, especially diagnostic biopsies before neoadjuvantly treated patients.